Insider · CIK 0001788249

Brenner Randall B.

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001788249

Forms 4 and 5

Insider transactions

31 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-09-21	Paratek Pharmaceuticals, Inc.D Disposition to Issuer	Chief Development & Regulatory	DDisposition to Issuer	−330K sh	—	—	85,500
2023-09-21	Paratek Pharmaceuticals, Inc.D Disposition to Issuer	Chief Development & Regulatory	DDisposition to Issuer	−85.5K sh	—	—	0
2023-08-09	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−27.6K sh	$2.20	−$60.7K	415,209
2023-08-08	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+67.5K sh	—	—	442,812
2022-12-21	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−4,539 sh	$1.99	−$9,032.61	335,312
2022-12-20	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+15K sh	—	—	339,851
2022-12-13	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−18.2K sh	$1.96	−$35.6K	324,851
2022-12-12	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−11.1K sh	$1.98	−$22K	343,028
2022-10-28	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−3,516 sh	$3.47	−$12.2K	354,133
2022-10-25	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+8,500 sh	—	—	357,649
2022-08-09	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−19.6K sh	$2.66	−$52.2K	349,149
2022-08-08	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+47.7K sh	—	—	368,757
2022-03-15	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+67.5K sh	—	—	321,030
2021-12-15	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−15.8K sh	$4.27	−$67.4K	253,530
2021-12-14	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−7,635 sh	$4.37	−$33.4K	269,310
2021-12-13	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−4,479 sh	$4.42	−$19.8K	276,945
2021-08-17	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−8,766 sh	$5.12	−$44.9K	281,424
2021-08-16	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+21.3K sh	—	—	290,190
2021-06-04	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−9,978 sh	$9.70	−$96.8K	268,940
2021-05-27	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+28.6K sh	—	—	278,918
2021-03-30	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+122K sh	—	—	250,282
2020-12-14	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−8,760 sh	$6.71	−$58.8K	128,782
2020-12-11	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−6,164 sh	$6.95	−$42.8K	137,542
2020-11-13	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−8,357 sh	$5.93	−$49.6K	143,706
2020-11-12	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+21.3K sh	—	—	152,063
2020-05-12	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−6,198 sh	$4.75	−$29.4K	130,813
2020-02-19	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+45K sh	—	—	137,011
2019-12-12	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−6,278 sh	$3.10	−$19.5K	92,011
2019-10-08	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−5,049 sh	$3.82	−$19.3K	98,289
2019-10-04	Paratek Pharmaceuticals, Inc.A Award	Chief Development & Regulatory	AAward	+12K sh	—	—	103,338
2019-10-03	Paratek Pharmaceuticals, Inc.S Sale	Chief Development & Regulatory	SSale	−7,674 sh	$3.98	−$30.5K	91,338

Recent filings

Accepted (ET)
Sep 214
Brenner Randall B.0000899243-23-019365
SEC(opens sec.gov)
Aug 104
Brenner Randall B.0000904454-23-000478
SEC(opens sec.gov)
Dec 224
Brenner Randall B.0000904454-22-000649
SEC(opens sec.gov)
Dec 144
Brenner Randall B.0000904454-22-000623
SEC(opens sec.gov)
Nov 14
Brenner Randall B.0000904454-22-000528
SEC(opens sec.gov)
Oct 274
Brenner Randall B.0000904454-22-000506
SEC(opens sec.gov)
Aug 104
Brenner Randall B.0000904454-22-000425
SEC(opens sec.gov)
Mar 234
Brenner Randall B.0000904454-22-000264
SEC(opens sec.gov)
Dec 154
Brenner Randall B.0000904454-21-000844
SEC(opens sec.gov)
Aug 184
Brenner Randall B.0000904454-21-000624
SEC(opens sec.gov)
Jun 84
Brenner Randall B.0000904454-21-000516
SEC(opens sec.gov)

Companies

Paratek Pharmaceuticals, Inc.Chief Development & Regulatory

Address

C/O PARATEK PHARMACEUTICALS, INC. 75 PARK PLAZA, 4TH FLOOR

BOSTON, MA, 02116